ENTX - enterabio.com Debt to Book Capitalization Ratio
Entera Bio Ltd. (ENTX) is developing an ecosystem of oral medications for osteoporosis treatment, attracting patients with the convenience of tablets. The model scales via patents for the delivery of injectable agents, ensuring global revenue. This chart of the financial debt-to-book capitalization ratio on GURU.Markets contains the current value of 0.06, helping to assess the diversification risks of research across various hormonal pathologies.
%20Debt%20to%20Net%20Assets%20Ratio&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_ENTX_-_Entera-Bio-Ltd._-_Debt-to-Net-Assets-Ratio "Entera Bio Ltd - ENTX Debt to Book Capitalization Ratio (period 07/04/2022 - 10/27/2026) | 👁️GURU.Markets👁️")
enterabio.com (ENTX) - metric breakdowns and financial figures
Entera Bio Ltd. specializes in innovative peptide therapy, focusing on the protection of intellectual property. This total debt-to-equity ratio tracks the daily dependence of borrowed funds on equity. The metric measures financial leverage, determining the proportion of leverage within the asset structure. An increase in this indicator signals R&D investments funded through borrowing. The stability of the indicator confirms the company's resilience to market shocks.